Zura Bio Ltd
Developing novel dual-pathway therapies for severe autoimmune and inflammatory conditions.
ZURA | US
Overview
Corporate Details
- ISIN(s):
- KYG507521071 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4225 EXECUTIVE SQUARE, 92037 LA JOLLA
- Website:
- https://zurabio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Zura Bio Ltd. is a clinical-stage, multi-asset immunology company focused on developing novel medicines for severe autoimmune and inflammatory conditions. The company's approach centers on dual-pathway biology, aiming to create transformative therapies for patients underserved by single-pathway treatments. Its development portfolio includes several therapeutic candidates, notably tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880). Zura Bio is focused on demonstrating the efficacy, safety, and dosing convenience of its assets to significantly improve patient well-being.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Zura Bio Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Zura Bio Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Zura Bio Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
